Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
630 participants
INTERVENTIONAL
2008-02-29
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific Aim 1 - To compare the prevalence of adenomas detected by standard colonoscopy, high-definition white light colonoscopy and NBI.
Specific Aim 2 - To compare the number of adenoma detected per subject by standard colonoscopy, high-definition white light colonoscopy and NBI.
Specific Aim 3 - To compare the accuracy of predicting polyp histology between standard colonoscopy, high-definition white light colonoscopy and NBI by evaluating the surface mucosal and vascular patterns during the procedure.
Specific Aim 4 - To determine the inter-observer agreement between investigators for the recognition of various polyp patterns
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective, Single Blinded Study for Predicting Colon Polyp Histology With Narrow Band Imaging
NCT00613262
Study of Flat Polyp Detection Using New Narrow Band Imaging (NBI) Compared to White Light Colonoscopy - The FIND FLAT Colonoscopy Study
NCT01310699
Clinical Evaluation of Narrow Band Imaging Colonoscope
NCT00628147
Comparison of Narrow Band Imaging With or Without Magnifying Colonoscopy
NCT01577875
Blue Laser Imaging and White Light Imaging Colonic Polyps
NCT03421600
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All colonoscopies will be performed at the Kansas City VA Medical Center and The Barnes Jewish Hospital, St Louis, MO. Moderate sedation will be administered for the procedure with intravenous midazolam, demerol or fentanyl and Propofol. In patients randomized to the NBI arm, the colonoscope will be inserted to the cecum under white light and will switch to NBI mode at the time of withdrawal. After cecal intubation, the colonic mucosa will be carefully visualized during withdrawal of the scope with one of the three imaging modalities to which the patient has been randomized. No effort will be made to look for polyps during the insertion of the colonoscope. All polyps detected will be documented for their size, morphology (Polypoid: sessile, pedunculated or Non polypoid: superficially elevated, completely flat, depressed), and location. The surface of the polyp will be assessed during the procedure and the histology will be predicted real time by evaluating the surface mucosal and vascular patterns. The patterns would be classified into one of the four patterns described in our pilot study (tubular and gyrus patterns will be combined to tubulogyrus pattern). Any other patterns detected would be described and kept in the miscellaneous category. If a pattern is not identified on a polyp with either white light or NBI, it will be recorded as such and no attempts will be made to predict histology. Photo documentation of the surface patterns of the polyps will be performed. Polyps will then be removed either with a biopsy forcep or snare and sent for histopathological evaluation. Each polyp removed will have one or more corresponding picture of its surface patterns and these will be labeled accordingly. The total time spent in inspecting the colonic mucosa (excluding the time spent in removal of polyps or clearing the colon of liquid and solid debris) will be measured with a stop watch. Representative images of the various polyp patterns will be reviewed, discussed and standardized amongst all the investigators at both sites. In addition, images of all the polyp patterns will be printed and posted in the endoscopy suites at both hospitals.
The bowel preparation will be evaluated and graded as follow:
Excellent (score=1) - \>90% mucosa seen, mostly liquid colonic contents, minimal suctioning needed for adequate visualization.
Good (score=2) - \>90% of mucosa seen, mostly liquid colonic contents, significant suctioning needed for adequate visualization Fair (score=3) - \> 90% mucosa seen, mixture of liquid and semisolid colonic contents, could be suctioned and/or washed Inadequate (score=4) - \<90% mucosa seen, mixture of semisolid ands solid colonic contents, which could not be suctioned or washed
Patients with "Inadequate" (score = 4) bowel prep will be excluded.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Standard White Light Colonoscopy
standard of care colonoscopy
Standard White Light Colonoscopy
one exam per patient
2
High Definition White Light Colonoscopy
standard of care colonoscopy
High Definition White Light Colonoscopy
one exam per patient
3
Narrow Band Imaging Colonoscopy
colonoscopy
Narrow Band Imaging Colonoscopy
one exam per patient
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
standard of care colonoscopy
Standard White Light Colonoscopy
one exam per patient
colonoscopy
Narrow Band Imaging Colonoscopy
one exam per patient
standard of care colonoscopy
High Definition White Light Colonoscopy
one exam per patient
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the ability to provide informed consent
Exclusion Criteria
* prior history of colon cancer
* history of inflammatory bowel disease
* use of anti-platelet agents or anticoagulants that precludes removal of polyps during the procedure
* poor general condition or any other reason to avoid prolonged procedure time
* history of polyposis syndrome or HNPCC
* inability to give informed consent.
* Inadequate bowel preparation
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Society for Gastrointestinal Endoscopy
OTHER
Midwest Biomedical Research Foundation
OTHER
Kansas City Veteran Affairs Medical Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kansas City VA Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amit Rastogi, MD
Role: PRINCIPAL_INVESTIGATOR
Kansas City VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kansas City VA Medical Center
Kansas City, Missouri, United States
Barnes Jewish Hospital
St Louis, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rastogi A, Early DS, Gupta N, Bansal A, Singh V, Ansstas M, Jonnalagadda SS, Hovis CE, Gaddam S, Wani SB, Edmundowicz SA, Sharma P. Randomized, controlled trial of standard-definition white-light, high-definition white-light, and narrow-band imaging colonoscopy for the detection of colon polyps and prediction of polyp histology. Gastrointest Endosc. 2011 Sep;74(3):593-602. doi: 10.1016/j.gie.2011.04.050. Epub 2011 Jul 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AR0003
Identifier Type: -
Identifier Source: secondary_id
AR0003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.